{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:29:16Z","timestamp":1787016556800,"version":"build-2736575974"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1124\/jpet.120.000229","type":"journal-article","created":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T14:25:17Z","timestamp":1611671117000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Optimization of Lipophilic Metalloporphyrins Modifies Disease Outcomes in a Rat Model of Parkinsonism"],"prefix":"10.1016","volume":"377","author":[{"given":"Li-Ping","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Fulton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica L.","family":"Bradshaw-Pierce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Pearson-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.120.000229_bib1","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1749-6632.2003.tb07470.x","article-title":"Mitochondria, oxidative damage, and inflammation in Parkinson\u2019s disease","volume":"991","author":"Beal","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1124\/jpet.120.000229_bib2","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1471-4159.1990.tb03143.x","article-title":"Kynurenine pathway measurements in Huntington\u2019s disease striatum: evidence for reduced formation of kynurenic acid","volume":"55","author":"Beal","year":"1990","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.120.000229_bib3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1460-9568.2006.05285.x","article-title":"Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model","volume":"25","author":"Blandini","year":"2007","journal-title":"Eur J Neurosci"},{"key":"10.1124\/jpet.120.000229_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fnana.2015.00091","article-title":"Oxidative stress and Parkinson\u2019s disease","volume":"9","author":"Blesa","year":"2015","journal-title":"Front Neuroanat"},{"key":"10.1124\/jpet.120.000229_bib5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0301-0082(01)00003-X","article-title":"Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson\u2019s disease","volume":"65","author":"Blum","year":"2001","journal-title":"Prog Neurobiol"},{"key":"10.1124\/jpet.120.000229_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0304-3940(95)12192-7","article-title":"Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer\u2019s and de novo Parkinson\u2019s disease patients","volume":"202","author":"Blum-Degen","year":"1995","journal-title":"Neurosci Lett"},{"key":"10.1124\/jpet.120.000229_bib7","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1124\/jpet.107.132134","article-title":"Inhibition of mitochondrial hydrogen peroxide production by lipophilic metalloporphyrins","volume":"324","author":"Castello","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.120.000229_bib8","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/(SICI)1098-1136(199603)16:3<276::AID-GLIA10>3.0.CO;2-X","article-title":"Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism","volume":"16","author":"Chao","year":"1996","journal-title":"Glia"},{"key":"10.1124\/jpet.120.000229_bib9","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1046\/j.1460-9568.2002.01938.x","article-title":"Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging","volume":"15","author":"Cicchetti","year":"2002","journal-title":"Eur J Neurosci"},{"key":"10.1124\/jpet.120.000229_bib10","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1016\/S0021-9258(19)42751-8","article-title":"The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents","volume":"249","author":"Cohen","year":"1974","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.120.000229_bib11","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-2-14","article-title":"Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition","volume":"2","author":"Croisier","year":"2005","journal-title":"J Neuroinflammation"},{"key":"10.1124\/jpet.120.000229_bib12","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1359-6446(04)03139-3","article-title":"Catalytic antioxidants: a radical approach to new therapeutics","volume":"9","author":"Day","year":"2004","journal-title":"Drug Discov Today"},{"key":"10.1124\/jpet.120.000229_bib13","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1111\/j.1460-9568.2003.03014.x","article-title":"Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson\u2019s disease","volume":"18","author":"Depino","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1124\/jpet.120.000229_bib14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/exnr.2002.7891","article-title":"Modeling Parkinson\u2019s disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway","volume":"175","author":"Deumens","year":"2002","journal-title":"Exp Neurol"},{"key":"10.1124\/jpet.120.000229_bib15","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JPD-130230","article-title":"The role of oxidative stress in Parkinson\u2019s disease","volume":"3","author":"Dias","year":"2013","journal-title":"J Parkinsons Dis"},{"key":"10.1124\/jpet.120.000229_bib16","doi-asserted-by":"crossref","first-page":"9257","DOI":"10.1074\/jbc.M115.708057","article-title":"Superoxide Dismutase (SOD)-mimetic M40403 is protective in cell and fly models of paraquat toxicity: implications for Parkinson disease","volume":"291","author":"Filograna","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.120.000229_bib17","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0026-895X(25)13535-9","article-title":"Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones","volume":"14","author":"Graham","year":"1978","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.120.000229_bib18","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1023\/A:1015863824277","article-title":"Plasma concentration clamping in the rat using a computer-controlled infusion pump","volume":"9","author":"Gustafsson","year":"1992","journal-title":"Pharm Res"},{"key":"10.1124\/jpet.120.000229_bib19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0006-8993(01)02681-6","article-title":"Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum","volume":"909","author":"He","year":"2001","journal-title":"Brain Res"},{"key":"10.1124\/jpet.120.000229_bib20","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/ncpneuro0924","article-title":"Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis","volume":"4","author":"Henchcliffe","year":"2008","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1124\/jpet.120.000229_bib21","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0197-0186(96)00078-2","article-title":"Cytokine-mediated neuronal apoptosis","volume":"30","author":"Hu","year":"1997","journal-title":"Neurochem Int"},{"issue":"Suppl 3","key":"10.1124\/jpet.120.000229_bib22","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1002\/ana.10483","article-title":"Oxidative stress in Parkinson\u2019s disease","volume":"53","author":"Jenner","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1124\/jpet.120.000229_bib23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0378-4347(01)00531-X","article-title":"High-performance liquid chromatography with spectrophotometric and electrochemical detection of a series of manganese(III) cationic porphyrins","volume":"767","author":"Kachadourian","year":"2002","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1124\/jpet.120.000229_bib24","doi-asserted-by":"crossref","first-page":"20026","DOI":"10.1074\/jbc.M109218200","article-title":"Macrophage\/microglia-specific protein Iba1 enhances membrane ruffling and Rac activation via phospholipase C-gamma -dependent pathway","volume":"277","author":"Kanazawa","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.120.000229_bib25","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/ana.410320612","article-title":"Platelet mitochondrial function in Parkinson\u2019s disease","volume":"32","author":"Krige","year":"1992","journal-title":"Ann Neurol"},{"key":"10.1124\/jpet.120.000229_bib26","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1046\/j.1471-4159.1995.64041703.x","article-title":"Free radical-generated neurotoxicity of 6-hydroxydopamine","volume":"64","author":"Kumar","year":"1995","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.120.000229_bib27","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1523\/JNEUROSCI.0019-07.2007","article-title":"An orally active catalytic metalloporphyrin protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in vivo","volume":"27","author":"Liang","year":"2007","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.120.000229_bib28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.taap.2017.04.004","article-title":"Pre-clinical therapeutic development of a series of metalloporphyrins for Parkinson\u2019s disease","volume":"326","author":"Liang","year":"2017","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/jpet.120.000229_bib29","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1111\/j.1471-4159.2004.02567.x","article-title":"Iron-sulfur enzyme mediated mitochondrial superoxide toxicity in experimental Parkinson\u2019s disease","volume":"90","author":"Liang","year":"2004","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.120.000229_bib30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.redox.2018.10.010","article-title":"Neuroprotective effects of a catalytic antioxidant in a rat nerve agent model","volume":"20","author":"Liang","year":"2019","journal-title":"Redox Biol"},{"key":"10.1124\/jpet.120.000229_bib31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.expneurol.2017.08.009","article-title":"Scavenging reactive oxygen species inhibits status epilepticus-induced neuroinflammation","volume":"298","author":"McElroy","year":"2017","journal-title":"Exp Neurol"},{"key":"10.1124\/jpet.120.000229_bib32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0304-3940(94)90508-8","article-title":"Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients","volume":"180","author":"Mogi","year":"1994","journal-title":"Neurosci Lett"},{"key":"10.1124\/jpet.120.000229_bib33","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0304-3940(94)90746-3","article-title":"Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients","volume":"165","author":"Mogi","year":"1994","journal-title":"Neurosci Lett"},{"key":"10.1124\/jpet.120.000229_bib34","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1600-0404.1998.tb01736.x","article-title":"Interleukin-6 levels in cerebrospinal fluid inversely correlate to severity of Parkinson\u2019s disease","volume":"98","author":"M\u00fcller","year":"1998","journal-title":"Acta Neurol Scand"},{"key":"10.1124\/jpet.120.000229_bib35","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2174\/1381612053381620","article-title":"Inflammatory process in Parkinson\u2019s disease: role for cytokines","volume":"11","author":"Nagatsu","year":"2005","journal-title":"Curr Pharm Des"},{"key":"10.1124\/jpet.120.000229_bib36","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.tips.2016.06.007","article-title":"Targeting oxidative stress in central nervous system disorders","volume":"37","author":"Patel","year":"2016","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.120.000229_bib37","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1995"},{"key":"10.1124\/jpet.120.000229_bib38","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/0361-9230(92)90142-K","article-title":"Vitamin E attenuates the toxic effects of 6-hydroxydopamine on free radical scavenging systems in rat brain","volume":"29","author":"Perumal","year":"1992","journal-title":"Brain Res Bull"},{"issue":"Suppl 1","key":"10.1124\/jpet.120.000229_bib39","doi-asserted-by":"crossref","first-page":"S207","DOI":"10.1016\/S1353-8020(11)70064-5","article-title":"Neurodegeneration and inflammation in Parkinson\u2019s disease","volume":"18","author":"Phani","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"issue":"Suppl 1","key":"10.1124\/jpet.120.000229_bib40","first-page":"35","article-title":"Mechanisms of MPTP toxicity","volume":"13","author":"Przedborski","year":"1998","journal-title":"Mov Disord"},{"key":"10.1124\/jpet.120.000229_bib41","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0306-4522(95)00066-R","article-title":"Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine","volume":"67","author":"Przedborski","year":"1995","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.120.000229_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-2952(75)90304-4","article-title":"Mechanisms of action of 6-hydroxydopamine","volume":"24","author":"Sachs","year":"1975","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.120.000229_bib43","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0306-4522(94)90605-X","article-title":"Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat","volume":"59","author":"Sauer","year":"1994","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.120.000229_bib44","doi-asserted-by":"crossref","first-page":"32467","DOI":"10.1074\/jbc.M910169199","article-title":"Tyrosine nitration by peroxynitrite formed from nitric oxide and superoxide generated by xanthine oxidase","volume":"275","author":"Sawa","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.120.000229_bib45","first-page":"373","article-title":"Role of cytokines in inflammatory process in Parkinson\u2019s disease","volume":"70","author":"Sawada","year":"2006","journal-title":"J Neural Transm Suppl"},{"key":"10.1124\/jpet.120.000229_bib46","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","article-title":"Mitochondrial complex I deficiency in Parkinson\u2019s disease","volume":"54","author":"Schapira","year":"1990","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.120.000229_bib47","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0006-8993(70)90187-3","article-title":"Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system","volume":"24","author":"Ungerstedt","year":"1970","journal-title":"Brain Res"},{"key":"10.1124\/jpet.120.000229_bib48","first-page":"421","article-title":"Behavioral, physiological, and neurochemical changes after 6-hydroxydopamine-induced degeneration of the nigro-striatal dopamine neurons","volume":"5","author":"Ungerstedt","year":"1974","journal-title":"Adv Neurol"},{"key":"10.1124\/jpet.120.000229_bib49","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1471-4159.1970.tb02210.x","article-title":"Effects of 6-hydroxydopamine on catecholamine containing neurones in the rat brain","volume":"17","author":"Uretsky","year":"1970","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.120.000229_bib50","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","article-title":"Free radicals and antioxidants in normal physiological functions and human disease","volume":"39","author":"Valko","year":"2007","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1124\/jpet.120.000229_bib51","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0166-2236(98)01362-9","article-title":"Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias","volume":"22","author":"West","year":"1999","journal-title":"Trends Neurosci"},{"key":"10.1124\/jpet.120.000229_bib52","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","article-title":"Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease","volume":"22","author":"Wu","year":"2002","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.120.000229_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10072-010-0424-0","article-title":"Role of glial cells in neurotoxin-induced animal models of Parkinson\u2019s disease","volume":"32","author":"Yokoyama","year":"2011","journal-title":"Neurol Sci"},{"key":"10.1124\/jpet.120.000229_bib54","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1021\/acschemneuro.8b00454","article-title":"Impact of dopamine oxidation on dopaminergic neurodegeneration","volume":"10","author":"Zhang","year":"2019","journal-title":"ACS Chem Neurosci"},{"key":"10.1124\/jpet.120.000229_bib55","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1006\/nbdi.2000.0319","article-title":"Oxidative stress and genetics in the pathogenesis of Parkinson\u2019s disease","volume":"7","author":"Zhang","year":"2000","journal-title":"Neurobiol Dis"},{"key":"10.1124\/jpet.120.000229_bib56","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1196\/annals.1427.023","article-title":"Oxidative stress in Parkinson\u2019s disease: a mechanism of pathogenic and therapeutic significance","volume":"1147","author":"Zhou","year":"2008","journal-title":"Ann N Y Acad Sci"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524270518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524270518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.120.000229","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:01:47Z","timestamp":1739955707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524270518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0022356524270518"],"URL":"https:\/\/doi.org\/10.1124\/jpet.120.000229","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimization of Lipophilic Metalloporphyrins Modifies Disease Outcomes in a Rat Model of Parkinsonism","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.120.000229","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}